Welcome and thank you for visiting the website of the biophysics department at the GSI in Darmstadt. The biophysics department is an interdisciplinary collaboration of biologists, physicists, chemists, biochemists and technicians.
The multidisciplinary research in our group covers many different topics which can be roughly summarized in the categories radiobiology, physics, space research and therapy.
The biophysics research at GSI is a part of a large international network of more than 40 groups from universities and other research Institutes.
24.11.2025 | Christoph-Schmelzer Award presented to two young researchers
(GSI-FAIR press release) Two young researchers have been awarded this year’s Christoph Schmelzer Prize: Dr. Cristina Totis from the Technical University of Darmstadt and Dr. Stefanie Bertschi from the Technical University of Dresden were honored for their outstanding doctoral theses. The award, presented annually by the Association for the Promotion of Tumor Therapy with Heavy Ions, recognizes exceptional research in the field of ion beam cancer therapy. The recipients accepted their awards on November 20 during a ceremonial event at the GSI/FAIR campus in Darmstadt. Read more >>
10.11.2025 | Giersch - Prize 2025 der HGSHire Graduate School
Ms. Amèlia Jansen van Vuuren, Mr. Malte Benje, Mr. Luca Lunati, and Mr. Peter Dick have been awarded the “Giersch Prize 2025 of the HGSHire Graduate School” for their outstanding scientific work in recent years. The award ceremony took on 10 November 2025 at the Frankfurt Institute for Advanced Studies (FIAS).
09.11.2025 | The Nov/Dec 2025 issue of the CERN courier
The Nov/Dec 2025 issue of the CERN Courier is largely dedicated to particle therapy and includes reports on our research at GSI. It includes interviews to Marco Durante and Francesca Luoni. Read the issue here:
It is the birthplace of a new form of cancer treatment. This development was the result of many years of research in conjunction with GSI’s large ion-beam accelerator system. The advantage of this new treatment modality is that the ion beam selectively damages tumor tissues while sparing the surrounding healthy tissues.
